Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis.
Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat.
Epigenetic changes in neurology: DNA methylation in multiple sclerosis.
Axoskeletal proteins prevent oligodendrocyte from toxic injury by upregulating survival, proliferation, and differentiation in vitro.
Immune cells after prolonged Natalizumab therapy: implications for effectiveness and safety.
Hypothermia, Hypotension, Hypersomnia, and Obesity Associated With Hypothalamic Lesions in a Patient Positive for the Anti-aquaporin 4 Antibody: A Case Report and Literature Review.
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis.
AP-1 Mediated Transcriptional Repression of Matrix Metalloproteinase-9 by Recruitment of Histone Deacetylase 1 in Response to Interferon β.
Mesenchymal Stem Cell treatment for autoimmune diseases: a critical review.
Compressive myelopathy: magnetic resonance imaging findings simulating idiopathic acute transverse myelopathy.
Targeting the shift from m1 to m2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil.
A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis
Multiple sclerosis: Five new things.
Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis.
Secukinumab: first global approval.
Smoking and Risk of Multiple Sclerosis: Evidence of Modification by NAT1 Variants.
Multiple sclerosis: TOWER confirms the efficacy of oral teriflunomide in MS.
Multiple Sclerosis and Venous Abnormalities: Medicine in the Age of Social Media.
Coping Strategies in Multiple Sclerosis Patients with Frontal Cognitive Disorders.
Survey results show that adults are willing to pay higher insurance premiums for generous coverage of specialty drugs.
[Autophagy and its role in protective and damaging inflammatory response].
Quality of Life Assessment in Patients with Multiple Sclerosis Receiving Interferon Beta-1a: A Comparative Longitudinal Study of Avonex and Its Biosimilar CinnoVex.
Astrocyte proliferation is regulated by the OGF-OGFr axis in vitro and in experimental autoimmune encephalomyelitis.
Fingolimod treatment promotes regulatory phenotype and function of B cells.
Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study.

Pages